NYSE : ELV
Elevance Health, Inc. — Key statistics
Healthcare · Healthcare Plans · United States
Last price 422.02 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 91.18B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 90.76B |
| Enterprise Value | 111.17B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | Dec 4, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 216.06M |
| Shares Outstanding | 216.06M |
| Shares Change (YoY) | -3.33% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 95.59% |
| Float | 215.57M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 17.92 |
| Forward PE | 14.59 |
| PS Ratio | 0.45 |
| Forward PS | 0.45 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 16.62 |
| P/FCF Ratio | 13.93 |
| P/OCF Ratio | 11.95 |
| PEG Ratio | 3.77 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 21.63 |
| EV / Sales | 0.55 |
| EV / EBITDA | 12.76 |
| EV / EBIT | 13.85 |
| EV / FCF | 17.07 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.47 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 3.47 |
| Debt / FCF | 4.72 |
| Interest Coverage | 5.55 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 11.48% |
| Return on Assets (ROA) | 4.00% |
| Return on Invested Capital (ROIC) | 8.65% |
| Return on Capital Employed (ROCE) | 9.89% |
| Weighted Average Cost of Capital (WACC) | 7.07% |
| Revenue Per Employee | $2.08M |
| Profits Per Employee | $52,925 |
| Employee Count | 97,100 |
| Asset Turnover | 1.61 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.15B |
| Effective Tax Rate | 18.35% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +24.89% |
| 50-Day Moving Average | 410.56 |
| 200-Day Moving Average | 372.35 |
| Relative Strength Index (RSI) | 50.77 |
| Average Volume (20 Days) | 1,345,801 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.14M |
| Short Previous Month | 5.34M |
| Short % of Shares Out | 2.38% |
| Short % of Float | 2.38% |
| Short Ratio (days to cover) | 4.04 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 201.83B |
| Gross Profit | 53.35B |
| Operating Income | 8.03B |
| Pretax Income | 6.25B |
| Net Income | 5.14B |
| EBITDA | 8.71B |
| EBIT | 8.03B |
| Earnings Per Share (EPS) | $23.44 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 37.85B |
| Total Debt | 30.76B |
| Net Cash | -20.41B |
| Net Cash Per Share | -$94.46 |
| Equity (Book Value) | 44.79B |
| Book Value Per Share | 206.75 |
| Working Capital | 21.86B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 7.60B |
| Capital Expenditures | -1.08B |
| Depreciation & Amortization | n/a |
| Net Borrowing | 588.00M |
| Free Cash Flow | 6.51B |
| FCF Per Share | $30.15 |
Margins
| Measure | Value |
|---|
| Gross Margin | 26.43% |
| Operating Margin | 3.98% |
| Pretax Margin | 3.10% |
| Profit Margin | 2.55% |
| EBITDA Margin | 4.32% |
| EBIT Margin | 3.98% |
| FCF Margin | 3.23% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $6.88 |
| Dividend Yield | 1.64% |
| Dividend Growth (YoY) | 0.58% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 29.36% |
| FCF Payout Ratio | 22.82% |
| Buyback Yield | 3.33% |
| Shareholder Yield | 4.97% |
| Earnings Yield | 5.58% |
| FCF Yield | 7.18% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $482.38 |
| Price Target Difference | 14.83% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 2.14% |
| EPS Growth Forecast (3Y) | 4.50% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |